Tuesday, November 5, 2024
HomeTagsACT Therapeutics

ACT Therapeutics

GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics

On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics